Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mail to Mr. West (analyst from Dutton)

Of course we do, but if Dutton says, the company is in a better shape TODAY, it means, the development with all the relating events should be seen as positive and thus I can't understand, why he doesn't take at least his first price target of $1,12. This defies logic IMO



Another example, in Nov 2006 and Feb 2007, I don't think that anyone fully aprreciated the effect of the Oct 2006 revoking of the anti-dilution agreement.





Share
New Message
Please login to post a reply